title: In vivo study of wound bursting strength and compliance of topical skin adhesives.
abstract: OBJECTIVE
  Over the past decade, the use of topical skin adhesives (TSA) for wound closure has increased. Among TSA characteristics, strength and flexibility are most important. Prior studies have compared the wound bursting strengths (WBSs) of the cyanoacrylates immediately after wound closure. In this study the authors compared the WBS and flexibility of multiple TSAs immediately and up to 2 days after closure.
  
  
  METHODS
  This was a controlled animal experiment. Two-centimeter incisions were created on both sides of 210 Sprague-Dawley rats and randomly closed with one of five commercially available TSAs (Dermabond [D], Indermil [I], Histoacryl [H], Liquiband [L], or GluStitch [G]). WBS and TSA flexibility were measured using the BTC-2000 device immediately after closure and at 1 and 2 days after closure. WBS and TSA flexibility were compared across groups with analysis of variance (ANOVA).
  
  
  RESULTS
  Wound bursting strengths were higher (p < 0.05) at 0, 1, and 2 days for D (274, 388, 232 mm Hg) than for all other TSAs (I 182, 225, and 107; H 189, 214, and 69; L 146, 118, and 75; or G 161, 150, and 73). TSA flexibility was also greater (p < 0.05) at 0, 1, and 2 days for D (36, 27, and 29 mm Hg/mm) than for all other TSAs (I 18, 14, and 12; H 18, 13, and 15; L 19, 14, and 12; G 26, 23, and 18).
  
  
  CONCLUSIONS
  The octyl-cyanoacrylate-based adhesive is significantly stronger and more flexible than all the butyl-cyanoacrylate-based adhesives at 0, 1 and 2 days after closure.
authors.affiliation: Department of Emergency Medicine, Stony Brook University, Stony Brook, NY, USA. adam.singer@stonybrook.edu
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Singer
authors.forename: Larry C
authors.initials: LC
authors.lastname: Perry
authors.forename: Robert L
authors.initials: RL
authors.lastname: Allen
mesh_terms: D000818:Animals; D003487:Cyanoacrylates / Q000627:therapeutic use; D004195:Disease Models, Animal; D008297:Male; D011897:Random Allocation; D051381:Rats; D013718:Tensile Strength; D014014:Tissue Adhesives / Q000627:therapeutic use*; D016896:Treatment Outcome; D014947:Wounds and Injuries / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D003487:Cyanoacrylates; D014014:Tissue Adhesives